TY  - JOUR
A1  - Streater, A
A1  - Spector, A
A1  - Aguirre, E
A1  - Stansfeld, J
A1  - Orrell, M
SN  - 1471-2288
KW  - Cognitive stimulation
KW  -  Cognitive Stimulation Therapy (CST)
KW  -  Dementia
KW  -  Implementation
KW  -  Implementation Readiness (ImpRess)
KW  -  Reporting
N2  - Background

Research reporting results of clinical trials, psychosocial or technological interventions frequently omit critical details needed to inform implementation in practice. The aim of this article is to develop an Implementation Readiness (ImpRess) checklist, that includes criteria deemed useful in measuring readiness for implementation and apply it to trials of cognitive stimulation in dementia, providing a systematic review of their readiness for widespread implementation.
Methods

Five electronic databases were searched. After initial screening of papers, two reviewers assessed quality and scored the included studies based on the ImpRess checklist specifically developed for this review.
Results

Twenty studies met the inclusion criteria. As determined by the ImpRess checklist, scores ranged from 11 to 29 out of 52. According to the checklist the most comprehensive and ready to implement version of cognitive stimulation was Cognitive Stimulation Therapy.
Conclusions

Reports of interventions rarely include consideration of implementation in practice. Contrary to the growing number of reporting guidelines, crucial items within the ImpRess checklist have been frequently overlooked. This study was able to show that the ImpRess checklist was feasible in practice and reliable. The checklist may be useful in evaluating readiness for implementation for other manualised interventions.
EP  - 9
AV  - public
ID  - discovery1533233
Y1  - 2016/12/01/
UR  - https://dx.doi.org/10.1186/s12874-016-0268-2
TI  - ImpRess: an Implementation Readiness checklist developed using a systematic review of randomised controlled trials assessing cognitive stimulation for dementia
N1  - This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
JF  - BMC MEDICAL RESEARCH METHODOLOGY
VL  - 16
PB  - BIOMED CENTRAL LTD
ER  -